Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1318359.
- Also identified by PMC identifier 489088.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 59 year old man with ischaemic heart disease, developed the clinical and electromyographic changes of the Lambert-Eaton myasthenic syndrome after taking calcium antagonist, diltiazem. The symptoms appeared periodically with a rise and fall in serum level of diltiazem. Extensive search was made for systemic neoplasms and autoimmune diseases without success. Serum antibody to voltage operated calcium channel was not detected.
Medical subject headings
- Autoantibodies
- Calcium Channels
- Coronary Disease
- Diltiazem
- Lambert-Eaton Myasthenic Syndrome